Estrogen Treatment in Acromegalic Women
Recruitment status was Recruiting
Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
|Study Start Date:||May 2006|
|Estimated Study Completion Date:||August 2007|
This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients with suboptimal response to sandostatin LAR treatment.
|Contact: Omar SERRI, MD||514-890-8000 ext firstname.lastname@example.org|
|CHUM - Notre-Dame Hospital||Recruiting|
|Montreal, Quebec, Canada, H2L 4M1|
|Principal Investigator: Omar Serri, MD|
|Principal Investigator:||Omar Serri, MD||CHUM- Endocrinology|